| Followers | 54 |
| Posts | 6684 |
| Boards Moderated | 0 |
| Alias Born | 01/11/2017 |
Tuesday, October 12, 2021 1:49:46 PM
Yea- the SEC filing. See, what Nader says and what Nader does are diametrically opposed. He exercised warrants for penny’s which technically went to the treasury then proceeded to see for $15m just prior to releasing a bad PR
Also, in the last EG video, the notable Nader Pourhassen was dumb enough to say he has more than enough money in his accounts should he be fired!
The money he’s accumulated taking bonus shares, stealing them and grifting! That’s his game… it’s all documented.
His comp last year was $10+ million. Do you think a no-revenue, multiple felon and trial failure like Nader deserves that kind of money? All at the expense of shareholders.
I got a better one for you- the last time 100 million shares was authorized, Nader in a “scheme of unmitigated greed” took 25 million for him, Kelly and a couple friends. Then the 13d group folks stepped in, sued Nader and he lost! Look up the magistrates quotes. To make it worse, Cytodyn footed the legal bills in excess of $1m and then he lost the illegal termination case against Pestell and lost another $7.5m in damages plus legal fees, all paid for by retail shareholders!
But hey, let’s not look backward only forward! Nader for Nobel Peace Prize
Also, in the last EG video, the notable Nader Pourhassen was dumb enough to say he has more than enough money in his accounts should he be fired!
The money he’s accumulated taking bonus shares, stealing them and grifting! That’s his game… it’s all documented.
His comp last year was $10+ million. Do you think a no-revenue, multiple felon and trial failure like Nader deserves that kind of money? All at the expense of shareholders.
I got a better one for you- the last time 100 million shares was authorized, Nader in a “scheme of unmitigated greed” took 25 million for him, Kelly and a couple friends. Then the 13d group folks stepped in, sued Nader and he lost! Look up the magistrates quotes. To make it worse, Cytodyn footed the legal bills in excess of $1m and then he lost the illegal termination case against Pestell and lost another $7.5m in damages plus legal fees, all paid for by retail shareholders!
But hey, let’s not look backward only forward! Nader for Nobel Peace Prize
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
